The FDA is now fast-tracking new drug approvals — why that’s so worrying
The Food and Drug Administration is now regularly approving new drugs after just one or two clinical trials — a significant departure from the more rigorous vetting process the agency was previously known for, newly published research reveals. Furthermore, the authors say, there’s now less information available to the public about the results of all trials. … Read more